table {mso-displayed-decimal-separator:"\."; mso-displayed-thousand-separator:"\,";} tr {mso-height-source:auto;} col {mso-width-source:auto;} td {padding-top:1px; padding-right:1px; padding-left:1px; mso-ignore:padding; color:black; font-size:12.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:"Aptos Narrow", sans-serif; mso-font-charset:0; text-align:general; vertical-align:bottom; border:none; white-space:nowrap; mso-rotate:0;} .xl51 {font-size:11.0pt; font-family:"Aptos Narrow"; mso-generic-font-family:auto; mso-font-charset:0; text-align:left; vertical-align:top; border:.5pt solid black; white-space:normal;}

STRM.BIO, Inc. in Cambridge, Mass. seeks to develop a novel delivery platform to transport therapeutic cargo to immune cells and treat autoimmune diseases